New Launch23 Oct 2025, 09:16 am
Fischer Medical Ventures' Portfolio Company, Nanomedic, Clears UK NHS Hurdle, Advances India Market Strategy, and Targets US FDA Submission
AI Summary
Fischer Medical Ventures Ltd. (FMVL) announced that its portfolio company, Nanomedic Technologies Ltd., has achieved significant milestones. These include the successful registration of Nanomedic’s flagship product, SpinCare®, with the UK’s National Health Service (NHS), strategic preparations for a large-scale launch in the Indian market, and proactive steps towards US FDA submission. The UK approval, India market strategy, and US FDA submission are the key highlights of this news.
Key Highlights
- Nanomedic’s SpinCare® product registered with the UK NHS, opening doors to a major healthcare system.
- Strategic preparations underway for a large-scale launch in the Indian market, with no direct competitors.
- Proactive steps towards US FDA submission, with a strong history of successful FDA submissions.
- Nanomedic reinforcing its structure to support global expansion, with key hires in operations, business development, sales, and clinical and North American regulatory affairs.
- SpinCare® technology validated by peer-reviewed evidence, showing significant pain relief, faster healing, and higher patient satisfaction.